Join to view full profile
7064 Corline CTSuite ASebastopol, CA 95472
Phone+1 707-829-5900
Fax+1 707-829-5282
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Isaac Eliaz, MD is a family physician in Sebastopol, California. He is currently licensed to practice medicine in California and Wisconsin.
Education & Training
Valley Consortium for Medical Education Family MedicineResidency, Family Medicine, 1999 - 2000
Tel Aviv University SacklerClass of 1988
Certifications & Licensure
CA State Medical License 1992 - 2028- CA State Medical License 1992 - 2026
WI State Medical License 2000 - 2005
Publications & Presentations
PubMed
- 9 citationsModified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study.Daniel Keizman, Moshe Frenkel, Avivit Peer, Eli Rosenbaum, David Sarid
Nutrients. 2023-08-11 - 20 citationsThe potential roles of galectin-3 in AKI and CKD.Fengyun Wang, Lixin Zhou, Amity Eliaz, Chang Hu, Xinhua Qiang
Frontiers in Physiology. 2023-01-01 - 17 citationsModified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, Igal Kushnir, Eli Rosenbaum
Nutrients. 2021-11-28
Press Mentions
253: Resiliency Radio with Dr. Jill: Galectin-3's Breakthrough for Mold & Environmental IllnessApril 21st, 2025- Terumo Blood and Cell Technologies Collaborates with Eliaz Therapeutics in the Development and Commercialization of a Novel Therapeutic Apheresis Treatment for Acute Kidney Injury (AKI)July 27th, 2022
- Peptides: A Promising Alternative to Opioids - Experts SayMay 10th, 2022
Grant Support
- Depleting Circulating Galectin-3 with Therapeutic Apheresis: A NovelTreatment for Sepsis/AKIELIAZ THERAPEUTICS, INC.2018–2025
- Depleting Circulating Galectin-3 with Therapeutic Apheresis: A NovelTreatment for Sepsis/AKIELIAZ THERAPEUTICS, INC.2018–2025
